Global Trust Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History
Global Trust Asset Management, LLC
- $266 Million
- Q3 2024
A detailed history of Global Trust Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 1,037 shares of VRTX stock, worth $488,551. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,037
Previous 817
26.93%
Holding current value
$488,551
Previous $382,000
26.18%
% of portfolio
0.18%
Previous 0.16%
Shares
18 transactions
Others Institutions Holding VRTX
# of Institutions
1,718Shares Held
226MCall Options Held
1.21MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$12.6 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.52 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.02 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...